Remove tag patient-care
article thumbnail

STAT+: A nonprofit does deals in Brazil and India to make low-cost CAR-T cell therapies widely available

STAT

The deals will initially involve manufacturing cell therapies for combating lymphoma and leukemia, which carry price tags in the hundreds of thousands of dollars in wealthy nations. By “But we’re not offering the same products that are approved for elsewhere. These are not generic versions.

312
312
article thumbnail

Hospitals want to buy doctors’ happiness with Nuance’s AI scribe. What they’re paying varies

STAT

Microsoft-owned Nuance Communications sells its AI medical scribe platform to health care providers on a simple promise: If they shell out big bucks for the high-tech product, they can decrease doctor burnout and ultimately make more money by enabling doctors to see more patients. Read the rest…

Hospitals 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: Some employers cut insurance coverage for weight loss drugs; U.S. urges ADHD pill makers to boost production

STAT

Spending on the popular drugs, which belong to the class including Ozempic and can cost as much as $1,350 a month for a patient, has quickly leapt into the tens of millions of dollars for insurance plans. Medicare and Medicaid patients will make up 92% of the market for the drug, called Leqembi. could qualify to use the drug.

173
173
article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy supplies, Biogen ditching Aduhelm, and more

STAT

… Novo Nordisk has begun to increase availability of its blockbuster obesity drug Wegovy for new patients in the U.S. In response to concerns over multi-million-dollar price tags for new gene therapies for sickle cell disease, the U.S. Meanwhile, do keep us in mind if you hear anything interesting.

Diabetes 200
article thumbnail

Haemophilia drug costing $3.5m per dose has been approved

Pharmafile

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. The treatment also seemed to free 94% of patients from expensive and time-consuming infusions of Factor IX, which is the current standard of care for the often fatal condition. Costing $3.5m

72
article thumbnail

BD partners with Biocorp on connected self-injection devices

pharmaphorum

Medtech giant Beckton Dickinson (BD) has signed a deal with France’s Biocorp to use the latter’s near-field communication (NFC) tags in injectable devices. The Injay tag can confirm a complete injection and transfer that information via an NFC reader to a smartphone or tablet for review by a healthcare professional.

article thumbnail

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

It also develops services to support the evolution of medical care and finding purposes in life, in collaboration with various research institutions and companies. In 2019 Cognitant and Addenbrook’s Hospital in Cambridge, UK piloted a programme that aimed to educate patients to improve adherence to rheumatoid arthritis medicines.

Hospitals 122